381
Participants
Start Date
March 22, 2023
Primary Completion Date
September 10, 2025
Study Completion Date
February 17, 2026
Secukinumab 300 mg
Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen
Secukinumab 150 mg
Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen
Placebo to secukinumab
Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen
Novartis Investigative Site, Budapest
Novartis Investigative Site, Fribourg
Novartis Investigative Site, Parramatta
Novartis Investigative Site, Leuven
Novartis Investigative Site, Heidelberg Heights
Novartis Investigative Site, Liège
Novartis Investigative Site, Basel
Novartis Investigative Site, Southport
Novartis Investigative Site, Esbjerg
Novartis Investigative Site, Szeged
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Panorama
Novartis Investigative Site, Stellenbosch
Novartis Investigative Site, Bruges
Novartis Investigative Site, Aarhus N
Novartis Investigative Site, Veszprém
Novartis Investigative Site, Sankt Gallen
Novartis Investigative Site, Gandrup
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Aix-en-Provence
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Dijon
Klein and Associates, Hagerstown
Novartis Investigative Site, Rendsburg
Novartis Investigative Site, Pavia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Brest
Southeastern Rheumatology Alliance, Gainesville
Novartis Investigative Site, Toulouse
UF Health Cancer Center, Gainesville
West Broward Rheumatology Associates Inc, Tamarac
Rheumatology Associates of South Florida, Boca Raton
Sarasota Arthritis Res Ctr, Sarasota
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Bolzano
Novartis Investigative Site, Ratingen
Novartis Investigative Site, Seville
Novartis Investigative Site, Reggio Emilia
Novartis Investigative Site, Nantes
Paramount Med Rsrch and Consult LLC, Middleburg Heights
Novartis Investigative Site, Herne
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Valencia
Novartis Investigative Site, Bilbao
Clinical Research Inst of MI, Saint Clair Shores
Novartis Investigative Site, Cholet
Novartis Investigative Site, Reims
Kansas City Physician Partners, Kansas City
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Colmar
Novartis Investigative Site, Le Mans
Prolato Clinical Research Center, Houston
DM Clinical Research, Houston
Advanced Rheumatology of Houston, Spring
Accurate Clinical Research Inc, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Toulon
AZ Arthritis and Rheumtlgy Rsh PLLC, Phoenix
Sun Valley Arthritis Center Ltd, Peoria
Arizona Arthritis and Rheumatology Associates PLLC, Avondale
Novartis Investigative Site, Limoges
Providence Saint Johns Health Ctr, Santa Monica
Novartis Investigative Site, Erlangen
Center for Rheumatology Research, West Hills
Millennium Clinical Trials, Westlake Village
Precn Comprehensive Clnl Rsch Solns, San Leandro
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Beirut
Novartis Investigative Site, Santiago de Cali
Novartis Investigative Site, Viña del Mar
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Santiago
Novartis Investigative Site, Santiago
Novartis Investigative Site, Santiago
Massachusetts General Hospital, Boston
Dartmouth Hitchcock Medical Center, Lebanon
Novartis Investigative Site, Quilmes
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Québec
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Brno
Novartis Investigative Site, Hlučín
Novartis Investigative Site, Prague
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Zlín
Novartis Investigative Site, Vejle
Novartis Investigative Site, Dresden
Novartis Investigative Site, Reykjavik
Novartis Investigative Site, Dublin
Novartis Investigative Site, Perugia
Novartis Investigative Site, Ichikawa
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Kita-gun
Novartis Investigative Site, Sagamihara
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Nagano
Novartis Investigative Site, Beppu
Novartis Investigative Site, Kawachi-Nagano
Novartis Investigative Site, Osaka
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Fuchū
Novartis Investigative Site, Ōme
Novartis Investigative Site, Shimonoseki
Novartis Investigative Site, Chūō
Novartis Investigative Site, Okayama
Novartis Investigative Site, Osaka
Novartis Investigative Site, Almelo
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Groningen
Novartis Investigative Site, Bytom
Novartis Investigative Site, Lublin
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Barnet
Novartis Investigative Site, Hull
Novartis Investigative Site, Wolverhampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY